Antiproliferative and Apoptotic Role of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) Benzenesulfonamide in Common Cancer Models

  title={Antiproliferative and Apoptotic Role of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) Benzenesulfonamide in Common Cancer Models},
  author={Yasin Tuluce and Gokhan Gorgisen and Ismail Musab Gulacar and Ismail Koyuncu and Mustafa Durgun and Suleyman Akocak and Halil Ozkol and Zehra Kaya},
  journal={AntiCancer Research},
  pages={5115 - 5120}
Background/Aim: Chemotherapeutic treatment options are often ineffective due to the development of resistance in cancer cells. Therefore, developing new anti-cancer agents is crucial for cancer treatment. Some triazine derivatives, their complexes and Copper(II) have anti-cancer effects on cancer cells. In this study, we aimed to determine the anti-proliferative effect of the novel synthesized Cu(II) complex with 3-(3-(4-fluorophenyl)triaz-1-en-1-yl) benzene-sulfonamide compound on the common… Expand
6 Citations
Novel Fluorine Boron Hybrid Complex as Potential Antiproliferative Drugs on Colorectal Cancer Cell Line.
The results suggest that the [L(BF2)2] as a novel fluorine boron hybrid complex can induce the apoptosis of HT-29 colorectal cancerous cell line and is become a possible candidate for future cancer studies. Expand
Synthesis and cytotoxic activities of novel copper and silver complexes of 1,3-diaryltriazene-substituted sulfonamides
Most of the metal complexes from the presented series showed to be more active against all cancerous cells than the uncomplexed 1,3-diaryltriazene-substituted sulfonamides, and lower cytotoxic effects observed on normal cells. Expand
Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
S-1 was able to induce apoptosis of cervical cancer cells and is a possible candidate for future anticancer studies. Expand
Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors.
The ureido benzenesulfonamides incorporating triazinyl moieties were investigated as inhibitors of four selected physiologically relevant human carbonic anhydrase isoforms involved in various diseases such as glaucoma, epilepsy, obesity and cancer. Expand
Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Most of the compounds showed high hCA IX selectivity over the abundant off-target isoforms hCA I and II, and may be considered of interest for further medicinal/pharmacologic studies. Expand
Pseudo-tetrahedral copper(II) complex derived from N'-[(2E,3Z)-4-hydroxy-4-phenylbut-3-en-2-ylidene]acetohydrazide: Synthesis, molecular structure, quantum chemical investigations, antioxidant and antiproliferative properties
Abstract The mononuclear copper(II) complex involving Schiff base ligand (HL) where HL = (N'-[(2E,3Z)-4-hydroxy-4-phenylbut-3-en-2-ylidene]acetohydraziede) was prepared and characterized by variousExpand


In vitro antiproliferative and apoptosis-inducing properties of a mononuclear copper(II) complex with dppz ligand, in two genotypically different breast cancer cell lines
The results indicate that the ER and/or p53 genotypes have a bearing on the efficacy of the complex as a cytotoxic agent since the response in the ER−ve and p53mutant MDA-MB-231 cell was not so prominent as in ER+ve andp53WT MCF-7 cell. Expand
Antitumor activity of resveratrol is independent of Cu(II) complex formation in MCF-7 cell line.
Resveratrol (Rsv) is widely reported to possess anticarcinogenic properties in a plethora of cellular and animal models having limited toxicity toward normal cells. In the molecular level, Rsv canExpand
Cytotoxic effects of a mixed ligand copper(II) chelate complex against a panel of human and murine cancer cells in vitro. Theoretical study of the mechanism of biologic action through molecular modelling.
Quantum-chemical calculations demonstrate that the mechanism of the cellular damage can be explained, at least in part, by the ability of the nucleobases and nucleotides to be subject to nucleophilic attack on copper. Expand
Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
Copper N-(2-hydroxyacetophenone) glycinate induces drug resistant leukemia cells to undergo apoptosis and proves to be a molecule having therapeutic potential to overcome MDR in cancer. Expand
New metal complexes as potential therapeutics.
Biological carriers conjugated to cisplatin analogs have improved specificity for tumor tissue, thereby reducing side effects and drug resistance, and metal-based chemotherapeutic compounds have the potential to modulate the biological properties of superoxide anion and nitric oxide. Expand
Cancer cell killing via ROS: To increase or decrease, that is the question
The paradox in the rationales of two opposite ROS-manipulation strategies and the concerns for their use are discussed, as well as a combinational set of cellular parameters including redox status, antioxidant enzymes expression, cell signaling and transcription factor activation profiles, namely "redox signaling signature", is waiting for being developed in order to choose ROS-elevating or ROS-depleting therapy specific to certain type of cancer cells. Expand
Copper in medicine: homeostasis, chelation therapy and antitumor drug design.
The most recent advances in copper homeostasis, copper-related chelation therapy and design of copper-based antitumor complexes will be summarized. Expand
Novel metals and metal complexes as platforms for cancer therapy.
Metals are essential cellular components selected by nature to function in several indispensable biochemical processes for living organisms. Metals are endowed with unique characteristics thatExpand
Copper complexes of 1-[(2-carboxyethyl)benzene]-3-[2-pyridine]triazene
The triazenide, 1-[(2-carboxyethyl)benzene]-3-[2-pyridine]triazene (HL), has been synthesized. In the presence of Et3N, the reaction of HL with Cu(OAc)2·H2O or CuCl2·2H2O gives the tetranuclearExpand
Oxidative DNA Damage Induced by Pirarubicin, an Anthracycline Anticancer Agent, in the Presence of Copper(II).
Findings suggest that pirarubicin plus Cu(II) induces oxidative DNA damage in a similar manner to doxorubic in, and Cu( II)-mediated oxidative DNADamage may serve as a common mechanism for antitumor effects of anthracyclines. Expand